Company
We believe synchronized drug delivery is life-saving precision.
We believe synchronized drug delivery is life-saving precision.
Precision in Every Breath, Innovation in Every Detail
AirICU is redefining critical care with advanced aerosol drug delivery systems designed to optimize medication delivery in intensive care settings. Our mission is simple yet profound: to empower clinicians with smart, synchronized solutions that enhance respiratory therapy, even in the most complex environments.

With a focus on intelligent nebulization technology, we’ve developed devices that integrate seamlessly into invasive and non-invasive ventilation systems—delivering medications more efficiently, more safely, and with greater consistency. By synchronizing drug delivery with the patient’s breathing cycle, AirICU minimizes waste, improves deposition, and supports faster, more effective outcomes.

We collaborate closely with healthcare professionals to shape the future of respiratory care—enhancing treatment precision, protecting care teams, reducing overall cost, and improving access to life-saving therapies. Together, we imagine an ICU where every breath is measured, every treatment counts, and every patient has a better chance at recovery.
The AirICU Story – a leader in intensive care nebulization area
AirICU belongs to the feellife group, a healthcare company centered around treating the upper and lower respiratory tracts of the human body. With the vision of "The Third Way of Dosing" and the technology core of "AiMesh ®" polymer nebulizer, feellife owns more than 250+ international invention patents and certificates, taking the leading position in the field of nebulized drug delivery, and the clinical nebulization equipment for hospital intensive care represented by "AirICU" has already benefited millions of patients in more than 40 countries and regions.
The AirICU Story – a leader in intensive care nebulization area
Facts about AirICU
Certificates and Patents
200+
Certificates and Patents
Sales and service in 40+ countries
40+
Sales and service in 40+ countries
Benefited around 2 millions Patients
2000000
Benefited around 2 millions Patients
Patient Testimonials
We help laryngectomy patients breathe again.
We help laryngectomy patients breathe again.
Aerotank empowers young patients to self-administer nebulization therapy.
Aerotank empowers young patients to self-administer nebulization therapy.
Our History
2024
• Received HCA Asia's Hospital Partnership of the Year.
2023
• Received the "World's Best Home Nebulizer Solution"award from the European media.
• Received the Global Vaccine Equipment Expert of the Year Award from Global Health & Medicine.
• Received MedTech Top 20 Innovative Healthcare Companies in the U.S.
• Air Smart Extra Lung Function Tester receives FDA K number.
2022
• Combination of global mesh nebulization ecology and modern traditional Chinese medicine innovation.
2019
• Launch the first AI intelligent nebulizer with imesh core technology worldwide.
2024
• Received HCA Asia's Hospital Partnership of the Year.
2023
• Received the "World's Best Home Nebulizer Solution"award from the European media.
• Received the Global Vaccine Equipment Expert of the Year Award from Global Health & Medicine.
• Received MedTech Top 20 Innovative Healthcare Companies in the U.S.
• Air Smart Extra Lung Function Tester receives FDA K number.
2022
• Combination of global mesh nebulization ecology and modern traditional Chinese medicine innovation.
2019
• Launch the first AI intelligent nebulizer with imesh core technology worldwide.
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Patent Achievements
Contact AirICU
AirICU
marketing@air-icu.com
202 N California Ave, City of Industry, CA 91744
Contact Us